# Protocolized Diuretic Strategy in Cardiorenal Failure

> **NCT01921829** · PHASE4 · TERMINATED · sponsor: **Kelly V. Liang, MD** · enrollment: 19 (actual)

## Conditions studied

- Cardiac Failure
- Renal Failure
- Kidney Failure

## Interventions

- **DRUG:** Protocolized Diuretic Strategy

## Key facts

- **NCT ID:** NCT01921829
- **Lead sponsor:** Kelly V. Liang, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Due to futility due to lower than expected recruitment
- **Last updated:** 2017-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01921829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01921829, "Protocolized Diuretic Strategy in Cardiorenal Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01921829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*